Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours.

Autor: Lawrence, Nicola J.1,2 nicola.lawrence@ctc.usyd.edu.au, Chan, Howard1,2 howa.chan@gmail.com, Toner, Guy1,3 guy.toner@petermac.org, Stockler, Martin R.1,2,4,5 martin.stockler@sydney.edu.au, Martin, Andrew1,2 andrew.martin@ctc.usyd.edu.au, Yip, Sonia1,2,6 sonia.yip@ctc.usyd.edu.au, Wong, Nicole1,2 nicole.wong@ctc.usyd.edu.au, Yeung, Annie1,2 annie.yeung@ctc.usyd.edu.au, Mazhar, Danish7 danish.mazhar@addenbrookes.nhs.uk, Pashankar, Farzana1,8 farzana.pashankar@yale.edu, Frazier, Lindsay1,9 lindsay_frazier@dfci.harvard.edu, McDermott, Ray1,10 raymcdermott@me.com, Walker, Roderick1,11,12 rick.walker@health.qld.gov.au, Tan, Hsiang1,13 hsiang.tan@sa.gov.au, Davis, Ian D.1,14 ian.davis@monash.edu, Grimison, Peter1,4 peter.grimison@lh.org.au, ANZUP (CORPORATE AUTHOR)
Zdroj: BMC Cancer. 8/29/2018, Vol. 18 Issue 1, p1-6. 6p. 1 Diagram, 2 Charts.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje